Sphera Funds Management as of Sept. 30, 2023
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 77 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 10.4 | $57M | 5.6M | 10.20 | |
Invesco Qqq Tr Put Put Option | 8.9 | $49M | 137k | 358.27 | |
Sanofi Sponsored Adr (SNY) | 4.9 | $27M | 500k | 53.64 | |
Nice Sponsored Adr (NICE) | 4.4 | $24M | 143k | 170.00 | |
Astrazeneca Sponsored Adr (AZN) | 3.5 | $19M | 285k | 67.72 | |
Enphase Energy Note 3/0 | 3.2 | $17M | 21M | 0.83 | |
Johnson & Johnson (JNJ) | 2.7 | $15M | 95k | 155.75 | |
Merck & Co (MRK) | 2.3 | $13M | 124k | 102.95 | |
Amazon (AMZN) | 2.2 | $12M | 95k | 127.12 | |
Tower Semiconductor Shs New (TSEM) | 2.1 | $12M | 470k | 24.56 | |
Syndax Pharmaceuticals (SNDX) | 2.0 | $11M | 773k | 14.52 | |
Microsoft Corporation (MSFT) | 2.0 | $11M | 34k | 315.75 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $9.2M | 259k | 35.65 | |
Bridgebio Pharma (BBIO) | 1.7 | $9.1M | 346k | 26.37 | |
Cytokinetics Com New (CYTK) | 1.6 | $8.8M | 299k | 29.46 | |
Novo-nordisk A S Adr (NVO) | 1.5 | $8.5M | 93k | 90.94 | |
Praxis Precision Medicines I | 1.5 | $8.3M | 4.9M | 1.71 | |
Celldex Therapeutics Com New (CLDX) | 1.4 | $7.7M | 280k | 27.52 | |
Eli Lilly & Co. (LLY) | 1.4 | $7.6M | 14k | 537.13 | |
Madrigal Pharmaceuticals (MDGL) | 1.4 | $7.4M | 51k | 146.04 | |
Springworks Therapeutics (SWTX) | 1.3 | $7.4M | 320k | 23.12 | |
Immatics SHS (IMTX) | 1.3 | $7.1M | 617k | 11.58 | |
Shl Telemedicine Sponsored Ads (SHLT) | 1.3 | $7.0M | 632k | 11.00 | |
Solaredge Technologies Call Option (SEDG) | 1.3 | $6.9M | 54k | 129.51 | |
Abbvie (ABBV) | 1.2 | $6.9M | 46k | 149.06 | |
Palo Alto Networks (PANW) | 1.2 | $6.7M | 29k | 234.44 | |
Biogen Idec (BIIB) | 1.2 | $6.6M | 26k | 257.01 | |
Day One Biopharmaceuticals I (DAWN) | 1.2 | $6.5M | 530k | 12.27 | |
Kura Oncology (KURA) | 1.2 | $6.4M | 703k | 9.12 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $6.4M | 36k | 177.10 | |
Point Biopharma Global | 1.2 | $6.4M | 953k | 6.67 | |
Novartis Sponsored Adr (NVS) | 1.1 | $6.1M | 60k | 101.86 | |
Sarepta Therapeutics (SRPT) | 1.1 | $6.1M | 50k | 121.22 | |
Merus N V (MRUS) | 1.1 | $6.0M | 253k | 23.58 | |
Disc Medicine (IRON) | 1.0 | $5.2M | 111k | 46.98 | |
Inozyme Pharma (INZY) | 0.9 | $5.2M | 1.2M | 4.20 | |
Advanced Micro Devices (AMD) | 0.9 | $5.0M | 48k | 102.82 | |
89bio (ETNB) | 0.9 | $4.9M | 319k | 15.44 | |
Ptc Therapeutics I (PTCT) | 0.9 | $4.9M | 219k | 22.41 | |
Inhibrx | 0.9 | $4.7M | 256k | 18.35 | |
Meta Platforms Cl A (META) | 0.8 | $4.6M | 15k | 300.21 | |
Gracell Biotechnologies Sponsored Ads | 0.8 | $4.4M | 1.5M | 2.88 | |
Astria Therapeutics (ATXS) | 0.8 | $4.3M | 581k | 7.46 | |
Mineralys Therapeutics (MLYS) | 0.8 | $4.3M | 455k | 9.51 | |
Rocket Pharmaceuticals (RCKT) | 0.8 | $4.3M | 209k | 20.49 | |
Xenon Pharmaceuticals (XENE) | 0.8 | $4.1M | 121k | 34.16 | |
Cogent Biosciences (COGT) | 0.7 | $4.1M | 420k | 9.75 | |
Jasper Therapeutics | 0.7 | $4.0M | 5.7M | 0.70 | |
Promis Neurosciences Com New (PMN) | 0.7 | $3.7M | 1.8M | 2.01 | |
Spdr Ser Tr S&p Biotech (XBI) | 0.7 | $3.7M | 50k | 73.02 | |
GSK Sponsored Adr (GSK) | 0.7 | $3.6M | 100k | 36.25 | |
Mirum Pharmaceuticals (MIRM) | 0.7 | $3.6M | 114k | 31.60 | |
Amylyx Pharmaceuticals (AMLX) | 0.6 | $3.5M | 194k | 18.31 | |
Fusion Pharmaceuticals | 0.6 | $3.5M | 1.4M | 2.60 | |
Replimune Group (REPL) | 0.6 | $3.2M | 185k | 17.11 | |
Gilead Sciences (GILD) | 0.5 | $3.0M | 40k | 74.94 | |
Pfizer (PFE) | 0.5 | $3.0M | 90k | 33.17 | |
Pliant Therapeutics (PLRX) | 0.5 | $2.7M | 156k | 17.34 | |
Icl Group SHS (ICL) | 0.5 | $2.6M | 470k | 5.55 | |
Crowdstrike Hldgs Cl A (CRWD) | 0.5 | $2.5M | 15k | 167.38 | |
Kezar Life Sciences | 0.4 | $2.4M | 2.1M | 1.19 | |
Morphic Hldg (MORF) | 0.4 | $2.1M | 90k | 22.91 | |
Alpine Immune Sciences | 0.4 | $2.1M | 180k | 11.45 | |
Gossamer Bio (GOSS) | 0.3 | $1.6M | 1.9M | 0.83 | |
Vera Therapeutics Cl A (VERA) | 0.3 | $1.4M | 105k | 13.71 | |
Werewolf Therapeutics (HOWL) | 0.2 | $1.3M | 627k | 2.14 | |
Rigel Pharmaceuticals Com New | 0.2 | $1.3M | 1.2M | 1.08 | |
Rezolute Com New (RZLT) | 0.2 | $1.3M | 997k | 1.32 | |
Compugen Ord (CGEN) | 0.2 | $1.2M | 1.3M | 0.93 | |
Mediwound Shs New (MDWD) | 0.2 | $1.2M | 109k | 10.64 | |
Uniqure Nv SHS (QURE) | 0.2 | $998k | 149k | 6.71 | |
Selecta Biosciences | 0.1 | $797k | 752k | 1.06 | |
Apogee Therapeutics (APGE) | 0.1 | $639k | 30k | 21.30 | |
Elevation Oncology (ELEV) | 0.1 | $596k | 900k | 0.66 | |
Vistagen Therapeutics Ord (VTGN) | 0.1 | $524k | 100k | 5.24 | |
Immatics *w Exp 07/01/202 (IMTXW) | 0.1 | $354k | 100k | 3.54 | |
Calliditas Therapeutics Ab Sponsered Ads | 0.0 | $217k | 12k | 18.26 |